Navigation Links
Infantile esotropia linked to developmental delays
Date:4/17/2008

Philadelphia, April 17, 2008 Babies with an eye-alignment disorder called infantile esotropia have delays in motor development milestones, but development catches up after corrective surgery, reports a study in the April Journal of AAPOS (American Association for Pediatric Ophthalmology and Strabismus).

Led by James R. Drover, PhD, of the Retina Foundation of Southwest Texas, Dallas, the researchers assessed developmental milestones in 161 infants with infantile esotropia, or crossed eyes. These infants need surgery on the eye muscles to correct the alignment. However, it has been unclear whether surgery to correct esotropia influences other aspects of infant development.

To answer this question, the researchers had parents complete an infant development questionnaire before and/or after corrective surgery. The questionnaire assessed fine-motor skills, such as grasping a toy and handling a bottle (sensorimotor development); as well are large-muscle skills, such as sitting, standing, and walking (gross motor development). A group of children with normal eye alignment were studied for comparison.

Before surgery, infants with esotropia had delays in both milestones. The developmental delays appeared as early as four to five months of age and were still present at ten months.

The sensorimotor delays were particularly profound, and probably reflected the importance of normal binocular vision (both eyes working together) in fine-muscle tasks. The delays in gross motor development, while not as severe, were still significant.

In contrast, infants tested after esotropia surgery had no delays in developmental milestones. In fact, they actually had a faster rate of sensorimotor development, suggesting that correcting their binocular vision helped their development to catch up to that of normal infants.

Infantile esotropia is one of a group of disorders called strabismus, in which the eyes are not aligned normally. Without surgery to correct the problem, depth perception cannot develop. Because vision develops rapidly between three to eight months of age, infantile esotropia might cause delays in developmental milestonesfor example, grasping objects, crawling, or walkingthat depend on normal vision. However, previous studies were unclear as to whether early surgery helps normal development, partly because many babies with esotropia are not sent for expert evaluation by a pediatric ophthalmologist until they are over one year old.

The new results show that babies with infantile esotropia have significant delays in developmental milestones before surgery, and, suggests that development catches up to normal after surgery to correct eye alignment. Dr. Drover and colleagues suspect that the rapid rate of development after surgery results from the improvement in binocular function.

Doctors continue to disagree over when is the best time to correct strabismus in children, because most of the focus has been on when it can best help their vision, comments Dr. David G. Hunter of Children's Hospital Boston and editor-in-chief of the Journal of AAPOS. This study says that surgery to correct strabismus doesn't just help the eyesit helps the whole child.


'/>"/>

Contact: Jayne Dawkins
ja.dawkins@elsevier.com
215-239-3674
Elsevier
Source:Eurekalert

Related medicine news :

1. Low Vitamin D Levels Linked to Leg Artery Blockages
2. Sleep Disorder Linked to Neurodegenerative Conditions
3. Heart Failure Drugs Linked to Hip Bone Loss in Older Men
4. Disturbances in brain circuitry linked to chronic exposure to solvents
5. Womens Awareness of Cancer Risk Linked to Race, Ethnicity
6. Diabetic Eye Problem Linked to Heart Failure
7. Hormone Replacement May Cut Risk for Age-Linked Eye Disease
8. Postmenopausal Womens Sexual Dissatisfaction Not Linked to Heart Troubles
9. Caffeine May Block High Cholesterol Linked to Alzheimers
10. Depression and Alzheimers Risk Linked
11. Vaccine Induced Inflammation Linked to Epidemic of Type 2 Diabetes and Metabolic Syndrome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World ... with chronic pain and the benefits of holistic treatments, Serenity Recovery Center ... with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association ... it will receive two significant new grants to support its work to advance ... 25th anniversary by recognizing patients, medical professionals and scientists for their work in ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda ... orthodontic treatment. Dr. Cheng has extensive experience with all areas of orthodontics, including ... accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. ...
(Date:6/24/2016)... ... 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ... raise to $12 an hour by 2020 and then adjusting it yearly to increase at ... the minimum wage, assure the wage floor does not erode again, and make future increases ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine ... Making in Emergency Medicine conference in Ponte Vedra Beach, FL. The awards honor ... Emergency Medicine Practice and Pediatric Emergency Medicine Practice. , “With this ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Tenn. , June 24, 2016  Arkis ... providing less invasive and more durable cerebrospinal fluid ... in funding.  The Series-A funding is led by ... Lighthouse Fund, and other private investors.  Arkis, new ... neurosurgical instrumentation and the market release of its ...
(Date:6/23/2016)... 2016 Research and Markets has ... by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), ... Parenteral) - Global Forecast to 2021" report to ... The global pharmaceutical excipients market is projected to reach ... 6.1% in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology: